Leukemia and stem cell research
Sadly, Ed Bradley died before stem cell research could save his life. ---BBB
This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at
http://cancer.gov or call 1-800-4-CANCER
Adult Acute Myeloid Leukemia
Treatment Options for Adult Acute Myeloid Leukemia
Untreated Adult Acute Myeloid Leukemia
Standard treatment of untreated adult acute myeloid leukemia (AML) during the remission induction phase depends on the subtype of AML and may include the following:
Combination chemotherapy.
High-dose combination chemotherapy.
Stem cell transplantation using donor stem cells.
All-trans retinoic acid (ATRA) plus chemotherapy.
Intrathecal chemotherapy.
Information about ongoing clinical trials is available from the NCI Web site.
Adult Acute Myeloid Leukemia in Remission
Standard treatment of adult AML during the remission phase depends on the subtype of AML and may include the following:
Combination chemotherapy.
High-dose chemotherapy, with or without radiation therapy, and stem cell transplantation using the patient's stem cells.
High-dose chemotherapy and stem cell transplantation using donor stem cells.
Adult Acute Myeloid Leukemia
Treatment Options for Adult Acute Myeloid Leukemia
Information about ongoing clinical trials is available from the NCI Web site.
Recurrent Adult Acute Myeloid Leukemia
Standard treatment of recurrent adult AML depends on the subtype of AML and may include the following:
Combination chemotherapy.
Biologic therapy with monoclonal antibodies.
Stem cell transplantation.
Low-dose radiation therapy as palliative therapy to relieve symptoms and improve quality of life.
Arsenic trioxide therapy.
Information about ongoing clinical trials is available from the NCI Web site.